- Home
- FRGE vs BIOA Comparison
FRGE vs BIOA Comparison
Compare FRGE & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRGE
- BIOA
- Stock Information
- Founded
- FRGE 2014
- BIOA 2015
- Country
- FRGE United States
- BIOA United States
- Employees
- FRGE N/A
- BIOA N/A
- Industry
- FRGE Computer Software: Prepackaged Software
- BIOA Biotechnology: Pharmaceutical Preparations
- Sector
- FRGE Technology
- BIOA Health Care
- Exchange
- FRGE Nasdaq
- BIOA Nasdaq
- Market Cap
- FRGE 175.1M
- BIOA 155.6M
- IPO Year
- FRGE N/A
- BIOA 2024
- Fundamental
- Price
- FRGE $18.93
- BIOA $4.13
- Analyst Decision
- FRGE Buy
- BIOA Hold
- Analyst Count
- FRGE 5
- BIOA 4
- Target Price
- FRGE $38.25
- BIOA $5.67
- AVG Volume (30 Days)
- FRGE 122.0K
- BIOA 460.8K
- Earning Date
- FRGE 08-06-2025
- BIOA 08-15-2025
- Dividend Yield
- FRGE N/A
- BIOA N/A
- EPS Growth
- FRGE N/A
- BIOA N/A
- EPS
- FRGE N/A
- BIOA N/A
- Revenue
- FRGE $85,383,000.00
- BIOA $1,451,000.00
- Revenue This Year
- FRGE $18.22
- BIOA N/A
- Revenue Next Year
- FRGE $29.35
- BIOA N/A
- P/E Ratio
- FRGE N/A
- BIOA N/A
- Revenue Growth
- FRGE 16.04
- BIOA N/A
- 52 Week Low
- FRGE $6.60
- BIOA $2.88
- 52 Week High
- FRGE $24.45
- BIOA $26.62
- Technical
- Relative Strength Index (RSI)
- FRGE 73.21
- BIOA N/A
- Support Level
- FRGE $18.15
- BIOA N/A
- Resistance Level
- FRGE $19.94
- BIOA N/A
- Average True Range (ATR)
- FRGE 0.97
- BIOA 0.00
- MACD
- FRGE 0.19
- BIOA 0.00
- Stochastic Oscillator
- FRGE 84.67
- BIOA 0.00
About FRGE Forge Global Holdings Inc.
Forge Global Holdings Inc is a financial service platform created to serve the needs of the private market. It provides marketplace infrastructure, data services, and technology solutions for private market participants. The company offers a trusted trading platform, proprietary data and insights to inform investment strategies, along with custody services to help companies, shareholders, institutions and accredited investors confidently navigate and transact in the private market.
About BIOA BioAge Labs Inc. Common Stock
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.